Lumida
/CE
⌘K
Celanese Corp

Celanese Corp

CE
$45.70USD-0.17%-0.08 today

MARKET CAP

5.0B

P/E (TTM)

10.6x

FWD P/E

6.9x

DAY RANGE

$45 – $47

52W RANGE

$35
$71

AI Summary

Stalk
Sell NowHigh

CE remains entrenched in a Stage 4 decline, confirmed by the active Support Failure pattern and a clear sequence of lower highs and lower lows. Price continues to trade below the 9-, 21-, 50-, and 200-day moving averages, with rallies into the EMAs repeatedly rejected. Despite extreme oversold readings, there is no visible exhaustion, and downside momentum looks set to continue. Execution should focus on selling into retracements back toward the declining EMAs.

  • Projects EPS gain of $1–2 in 2026 on strict cost savings.
  • Implements $30M in annual cost reductions to boost margins.
  • Revenue fell 10% YoY to $500M amid weak end-market demand.
Full analysis →
Insider Trades30 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Feb 15, 2026SellCEChuck KyrishSVP & CFO179$59.12$5.0B-35.36%+30.09%$10.6K-1.58%Sell Now
Feb 15, 2026SellCEAshley B DuffieSVP & GC183$59.12$5.0B-35.36%+30.09%$10.8K-0.87%Sell Now
Feb 15, 2026SellCEAaron M McgilvrayChief Accounting Officer188$59.12$5.0B-35.36%+30.09%$11.1K-1.79%Sell Now
Feb 15, 2026SellCEMark Christopher MurraySVP - Acetyls357$59.12$5.0B-35.36%+30.09%$21.1K-1.96%Sell Now
Feb 15, 2026SellCEScott A RichardsonCEO & President989$59.12$5.0B-35.36%+30.09%$58.5K-1.34%Sell Now
Dec 10, 2025BuyCEScott A RichardsonCEO & President3,800$41.59$5.0B-35.36%+30.09%$158.0K+5.70%Sell Now
Dec 9, 2025BuyCEChuck KyrishSVP & CFO5,000$41.03$5.0B-35.36%+30.09%$205.2K+84.54%Sell Now
Aug 14, 2025BuyCEMark Christopher MurraySVP - Acetyls2,017$41.83$5.0B-35.36%+30.09%$84.4K+13.46%Sell Now
Jul 13, 2025SellCEMark Christopher MurraySVP - Acetyls485$60.85$5.0B-35.36%+30.09%$29.5K-3.14%Sell Now
May 23, 2025BuyCEMark Christopher MurraySVP - Acetyls1,479$52.18$5.0B-35.36%+30.09%$77.2K+10.57%Sell Now
Mar 7, 2025BuyCEMark Christopher MurraySVP - Acetyls2,353$54.45$5.0B-35.36%+30.09%$128.1K+20.22%Sell Now
Feb 15, 2025SellCEAaron M McgilvrayChief Accounting Officer72$69.13$5.0B-35.36%+30.09%$5.0K-1.20%Sell Now
Feb 15, 2025SellCEAshley B DuffieSVP & GC174$69.13$5.0B-35.36%+30.09%$12.0K-1.24%Sell Now
Feb 15, 2025SellCEChuck KyrishSVP & CFO267$69.13$5.0B-35.36%+30.09%$18.5K-4.32%Sell Now
Feb 15, 2025SellCEMark Christopher MurraySVP - Acetyls364$69.13$5.0B-35.36%+30.09%$25.2K-3.03%Sell Now
Feb 15, 2025SellCEScott A RichardsonCEO & President964$69.13$5.0B-35.36%+30.09%$66.6K-1.43%Sell Now
Aug 19, 2024SellCEScott A RichardsonEVP & COO9,350$129.46$5.0B-35.36%+30.09%$1.2M-6.48%Sell Now
Jul 13, 2024SellCEMark Christopher MurraySVP - Acetyls471$140.58$5.0B-35.36%+30.09%$66.2K-4.06%Sell Now
Mar 14, 2024BuyCEThomas Francis KellySVP, EM1,400$156.69$5.0B-35.36%+30.09%$219.4K+2.52%Sell Now
Mar 14, 2024SellCEScott A RichardsonEVP & COO4,000$156.67$5.0B-35.36%+30.09%$626.7K-2.58%Sell Now
Mar 8, 2024BuyCEMark Christopher MurraySVP - Acetyls597$156.43$5.0B-35.36%+30.09%$93.4K+5.43%Sell Now
Feb 15, 2024SellCEMark Christopher MurraySVP - Acetyls124$150.82$5.0B-35.36%+30.09%$18.7K-1.11%Sell Now
Feb 15, 2024SellCEAaron M McgilvrayChief Accounting Officer371$150.82$5.0B-35.36%+30.09%$56.0K-5.96%Sell Now
Feb 15, 2024SellCEAshley B DuffieSVP & GC969$150.82$5.0B-35.36%+30.09%$146.1K-6.65%Sell Now
Feb 15, 2024SellCEChuck KyrishSVP & CFO1,560$150.82$5.0B-35.36%+30.09%$235.3K-21.28%Sell Now
Feb 15, 2024SellCEThomas Francis KellySVP, EM4,908$150.82$5.0B-35.36%+30.09%$740.2K-8.11%Sell Now
Feb 15, 2024SellCEScott A RichardsonEVP & COO8,134$150.82$5.0B-35.36%+30.09%$1.2M-9.40%Sell Now
Feb 15, 2024SellCELori RyerkerkChairman and CEO26,747$150.82$5.0B-35.36%+30.09%$4.0M-14.77%Sell Now
Dec 1, 2023SellCELori RyerkerkChairman and CEO150$141.04$5.0B-35.36%+30.09%$21.2K-0.13%Sell Now
Dec 1, 2023SellCEScott A RichardsonEVP & COO495$141.04$5.0B-35.36%+30.09%$69.8K-0.75%Sell Now